[Other] Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial |
|
This post will be closed automatically in 2026-06-25 06:03
Reward10points
|
20
Unveiling regional population structure in blackbelly rosefish Helicolenus dactylopterus through otolith shape analysis
20
Design Synthesis Through a Markov Decision Process and Reinforcement Learning Framework
10
Antibody-drug conjugates in gynaecological cancers: opportunities and challenges
1650
[Full book]Eifel-Trilobiten Teil: 2., Phacopida. - 1. Cheiruriden, Acasten, Asteropygen
20
Speed Is a Signal: When Faster Replies Increase Hiring Likelihood
